AI assistant
Adaptive Biotechnologies Corp — Director's Dealing 2019
Jun 27, 2019
31660_dirs_2019-06-26_ac615a36-6c69-4ce2-bcff-3bb1bb29df45.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Adaptive Biotechnologies Corp (ADPT)
CIK: 0001478320
Period of Report: 2019-06-26
Reporting Person: BENZENO SHARON (Sr VP, Drug Discovery)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $1.98 | 2024-10-13 | Common Stock (60000) | Direct | |
| Stock Option (Right to Buy) | $6.32 | 2026-09-16 | Common Stock (20000) | Direct | |
| Stock Option (Right to Buy) | $6.27 | 2027-04-25 | Common Stock (20000) | Direct | |
| Stock Option (Right to Buy) | $6.55 | 2028-02-07 | Common Stock (125000) | Direct | |
| Stock Option (Right to Buy) | $6.55 | 2028-10-01 | Common Stock (125000) | Direct | |
| Stock Option (Right to Buy) | $7.27 | 2029-02-07 | Common Stock (75000) | Direct |
Footnotes
F1: The options vested with respect to 1/4 of such shares on September 18, 2015, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F2: The options vested with respect to 1/4 of such shares on July 26, 2017, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F3: The options vested with respect to 1/4 of such shares on April 19, 2018, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F4: The options vested with respect to 1/4 of such shares on November 1, 2018, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F5: The options vest with respect to 1/4 of such shares on October 1, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F6: The options vest with respect to 1/4 of such shares on January 1, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.